Anti-seizure efficacy of nimodipine in pentylenetetrazole and kainic acid combined seizure models in mice

Indian Journal of Physiology and Pharmacology

Volumn 50, Issue 3, 2006, Pages 265-272

  Shitak, R ^b   Sahai, A K ^b   Hota, D ^a   Chakkabarti, A ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b INDIRA GANDHI MEDICAL COLLEGE   (India)

Author keywords

Kainic acid; Nimodipine; Pentylenetetrazole; Seizure

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; INTERCELLULAR ADHESION MOLECULE 3; KAINIC ACID; NIMODIPINE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; MALE; MOUSE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; SEIZURE;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CONVULSANTS; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; MICE; NIMODIPINE; PENTYLENETETRAZOLE; SEIZURES;

EID: 33747099968     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Coyle JT. Kainic acid: insight into excitatory mechanism causing selective neuronal degeneration. Clba Found Symp 1987; 126: 186-203.
2. Miettinen R, Kotti T, Tuunanen J, Toppinen A, Riekkinen P Sr, Halonen T. Hippocampal damage after injection of kainic acid into the rat entorhinal cortex. Brain Res 1998; 813: 9-17.
3. Yin HZ, Park DD, Lindsay AD, Weiss JH. Spinal cord neurons are vulnerable to rapidly triggered kainite neurotoxity in vitro. Brain Res 1995; 689: 265-270.
4. Krall RL, Penry JK, White BG, Kuferberg HJ, Swinyard EA. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978; 19: 409-428.
5. Giorgi O, Orlandi M, Lecca D, Corda MG. MK-801 prevents chemical kindling induced by Pentylenetetrazole in rats. Eur J Pharmacol 1991; 193: 363-365.
6. Ghosh MN. Toxicity Studies. In Fundamentals of Experimental Pharmacology (Ghosh MN ed) 3rd edition. Hilton & Company, Kolkata; 2005; 190-197.
7. Swinyard EA. Laboratory evaluation of antiepileptic drugs. Epilepsia 1969; 10: 107-119.
8. Okamota M, Sakiyama J, Mori S et al. Kainic acid induced convulsions causes prolonged changes in the chondroitin sulphate proteoglycan neurocan and phosphocan in the limbic structure. Exp Neurol 2003; 184: 179-195.
9. Ramanjaneyulu R, Ticku MJ. Interaction of pentamethylenetetrazole and tetrazole analogues with the picrotoxin site of benzodiazepine-GABA receptor- iontophore complex. Eur J Pharmacol 1984; 98: 337-345.
10. Meldrum BS. Amino acid neurotransmitters and new approaches to anticonvulsant drug action. Epilepsia 1984; 25(Suppl 2): S140-S149.
11. Monagham DT, Cotman CW. The distribution of [3H] kainic acid binding sites in rats CNS as determined by autoradiography. Brain Res 1982; 252: 91-100.
12. Perez MT, Davanger S. Distribution of GABA immunoreactivity in kainic acid treated rabbit retina. Exp Brain Res 1994; 100: 227-238.
13. 2+-permeable AMPA/Kainate channels in hippocampal pyramidal neurons. J Comp Neurol 1999; 409: 250-260.
14. 2+ channel blocker on aminophylline induced seizure models in rats. Brain Res Bull 1998; 45: 495-499.
15. 2+ antagonist. Epilepsia 1987; 28: 409-413.
16. 2+ channel antagonist nimodipine on kainic acid induced limbic seizures. Epilepsy Res 1990; 6: 33-38.
17. 2+ sensing receptor gene. Brain Res Bull 1997; 44: 75-84.
18. Johnston D, Brown TH. Mechanism of neuronal burst generations. In Electrophysiology of epilepsy (Schwartzkroin PS, Wheal HV eds) Academic Press, New York; 1984; 277-290.